Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
VNET: 4.40
52w: 3.51 - 18.86
(Bloomberg) -- Buyout firms CDH Investments and PAG are considering bids for US-listed Chinese data center company Vnet Group Inc., according to people familiar with the matter.
CDH and PAG have separately been exploring financing and deal structures for a potential offer, the people said, asking not to be identified because the matter is private. The investors could either bid on their own or form a consortium with other prospective bidders, the people said.
Considerations are ongoing and the companies could still decide against pursuing a transaction, they said. A representative for PAG declined to comment, while representatives for CDH and Vnet didn’t immediately respond to requests for comment.
Vnet last month received a preliminary non-binding takeover proposal from its founder and executive chairman Josh Sheng Chen at $8.20 per American depositary receipt in cash. Its board formed a special committee to evaluate the proposed transaction as well as other strategic alternatives, and is working with financial and legal advisers.
The approach followed a previous non-binding cash takeover in April from boutique Chinese advisory and private equity firm Hina Group and the Shanghai branch of Industrial Bank Co. to acquire Vnet’s shares for $8 per ADR.
Other companies considering bidding for Vnet include North Asia-focused investor MBK Partners, Bloomberg News has reported.
Founded in 1996, Vnet is a carrier-neutral data center services provider in China. It counts more than 50 data centers in more than 30 cities across China. The company formerly known as 21Vianet Group changed its name to Vnet Group last year.
CDH, an alternative investment fund manager focused on China, started in 2002 as a private equity platform and later expanded into other areas such as venture and growth capital, real assets, private credit, equities and private wealth management, according to its website. It had more than $26.6 billion of assets under management as of September last year.
PAG, an Asia-focused private equity firm backed by industry giant Blackstone Inc., counts about $50 billion in assets as of the end of June. It runs a variety of strategies including private equity, private debt, distressed, real estate and absolute return funds. The firm is considering delaying its planned initial public offering in Hong Kong amid market volatility, Bloomberg News has reported.
VNET: 4.40
52w: 3.51 - 18.86
(Bloomberg) -- Buyout firms CDH Investments and PAG are considering bids for US-listed Chinese data center company Vnet Group Inc., according to people familiar with the matter.
CDH and PAG have separately been exploring financing and deal structures for a potential offer, the people said, asking not to be identified because the matter is private. The investors could either bid on their own or form a consortium with other prospective bidders, the people said.
Considerations are ongoing and the companies could still decide against pursuing a transaction, they said. A representative for PAG declined to comment, while representatives for CDH and Vnet didn’t immediately respond to requests for comment.
Vnet last month received a preliminary non-binding takeover proposal from its founder and executive chairman Josh Sheng Chen at $8.20 per American depositary receipt in cash. Its board formed a special committee to evaluate the proposed transaction as well as other strategic alternatives, and is working with financial and legal advisers.
The approach followed a previous non-binding cash takeover in April from boutique Chinese advisory and private equity firm Hina Group and the Shanghai branch of Industrial Bank Co. to acquire Vnet’s shares for $8 per ADR.
Other companies considering bidding for Vnet include North Asia-focused investor MBK Partners, Bloomberg News has reported.
Founded in 1996, Vnet is a carrier-neutral data center services provider in China. It counts more than 50 data centers in more than 30 cities across China. The company formerly known as 21Vianet Group changed its name to Vnet Group last year.
CDH, an alternative investment fund manager focused on China, started in 2002 as a private equity platform and later expanded into other areas such as venture and growth capital, real assets, private credit, equities and private wealth management, according to its website. It had more than $26.6 billion of assets under management as of September last year.
PAG, an Asia-focused private equity firm backed by industry giant Blackstone Inc., counts about $50 billion in assets as of the end of June. It runs a variety of strategies including private equity, private debt, distressed, real estate and absolute return funds. The firm is considering delaying its planned initial public offering in Hong Kong amid market volatility, Bloomberg News has reported.
GAOTU TECHEDU INC -A- ADR (GOTU) 0,7924 +7,08%
2 year high: 142
Gaotu is a technology-driven education company and online large-class tutoring service provider in China. The Company offers educational services for college students and adults, non-academic tutoring services, and educational contents & digitalized learning products. Gaotu adopts an online live large-class format to deliver its courses, which the Company believes is the most effective and scalable model to disseminate scarce high-quality teaching resources to aspiring students in China. Big data analytics permeates every aspect of the Company's business and facilitates the application of the latest technology to improve teaching delivery, student learning experience, and operational efficiency.
https://ir.gaotu.cn/home
As of June 30, 2022, the Company had 172,397,205 ordinary shares outstanding
Total Cash (mrq) 3.35B
Total Cash Per Share (mrq) 12.96
Total Debt (mrq) 153.04M
Book Value Per Share (mrq) 11.68
GAOTU TECHEDU INC -A- ADR (GOTU) 0,7924 +7,08%
2 year high: 142
Gaotu is a technology-driven education company and online large-class tutoring service provider in China. The Company offers educational services for college students and adults, non-academic tutoring services, and educational contents & digitalized learning products. Gaotu adopts an online live large-class format to deliver its courses, which the Company believes is the most effective and scalable model to disseminate scarce high-quality teaching resources to aspiring students in China. Big data analytics permeates every aspect of the Company's business and facilitates the application of the latest technology to improve teaching delivery, student learning experience, and operational efficiency.
https://ir.gaotu.cn/home
As of June 30, 2022, the Company had 172,397,205 ordinary shares outstanding
Total Cash (mrq) 3.35B
Total Cash Per Share (mrq) 12.96
Total Debt (mrq) 153.04M
Book Value Per Share (mrq) 11.68
RECON TECHNOLOGY (RCON) : 0.9213
18 months high: 17.5
BEIJING, Oct. 25, 2022 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that Nanjing Recon Technology Co. has entered into a 2-year outsourced service agreement with a domestic customer to provide maintenance and overhaul services in an amount totaling approximately RMB3.2 million. Nanjing Recon Technology Co. is a variable interest entity of Hengda Technology (Beijing) Co., Ltd., a mainland China subsidiary of Recon.
The Company will provide services from October 1, 2022 to September 30, 2024 to cover the maintenance and related services for over 3200 safety instrumentations owned by the domestic customer.
Management Statement
Mr. Shenping Yin, Founder and CEO of Recon said, "We are glad to win another major contract for instrumentation maintenance. We believe safety in production is a very serious issue and has been a challenge for many large plants in China. We therefore have focused on markets related to security and maintenance services beginning the fiscal year 2020 and have been achieving steady returns in fiscal year 2022. We expect future revenue from this segment to be in excess of RMB20 million per year in fiscal year 2023."
About Recon Technology, Ltd ("RCON")
Recon Technology, Ltd (NASDAQ: RCON) is the People's Republic of China's first NASDAQ-listed non-state owned oil and gas field service company. Recon supplies China's largest oil exploration companies, Sinopec (NYSE: SNP) and The China National Petroleum Corporation ("CNPC"), with advanced automated technologies, efficient gathering and transportation equipment and reservoir stimulation measure for increasing petroleum extraction levels, reducing impurities and lowering production costs. Through the years, RCON has taken leading positions within several segmented markets of the oil and gas filed service industry. RCON also has developed stable long-term cooperation relationship with its major clients. For additional information please visit: http://www.recon.cn/.
RECON TECHNOLOGY (RCON) : 0.9213
18 months high: 17.5
BEIJING, Oct. 25, 2022 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that Nanjing Recon Technology Co. has entered into a 2-year outsourced service agreement with a domestic customer to provide maintenance and overhaul services in an amount totaling approximately RMB3.2 million. Nanjing Recon Technology Co. is a variable interest entity of Hengda Technology (Beijing) Co., Ltd., a mainland China subsidiary of Recon.
The Company will provide services from October 1, 2022 to September 30, 2024 to cover the maintenance and related services for over 3200 safety instrumentations owned by the domestic customer.
Management Statement
Mr. Shenping Yin, Founder and CEO of Recon said, "We are glad to win another major contract for instrumentation maintenance. We believe safety in production is a very serious issue and has been a challenge for many large plants in China. We therefore have focused on markets related to security and maintenance services beginning the fiscal year 2020 and have been achieving steady returns in fiscal year 2022. We expect future revenue from this segment to be in excess of RMB20 million per year in fiscal year 2023."
About Recon Technology, Ltd ("RCON")
Recon Technology, Ltd (NASDAQ: RCON) is the People's Republic of China's first NASDAQ-listed non-state owned oil and gas field service company. Recon supplies China's largest oil exploration companies, Sinopec (NYSE: SNP) and The China National Petroleum Corporation ("CNPC"), with advanced automated technologies, efficient gathering and transportation equipment and reservoir stimulation measure for increasing petroleum extraction levels, reducing impurities and lowering production costs. Through the years, RCON has taken leading positions within several segmented markets of the oil and gas filed service industry. RCON also has developed stable long-term cooperation relationship with its major clients. For additional information please visit: http://www.recon.cn/.
GAOTU TECHEDU INC -A- ADR (GOTU) 0,6611 -22,71%
2 year high: 142
Gaotu Techedu Inc, formerly GSX Techedu Inc, is a China-based holding company principally involved in the provision of technology-driven education services. Through its subsidiaries, the Company is engaged in the provision of online K-12 after-school tutoring services. It also offers foreign language, professional and interest courses. The Company conducts its businesses in Mainland China.
Shares Outstanding 258.6M
Float 137.36M
Total Cash (mrq) 3.35B
Total Cash Per Share (mrq) 12.96
Total Debt (mrq) 153.04M
Book Value Per Share (mrq) 11.68
GAOTU TECHEDU INC -A- ADR (GOTU) 0,6611 -22,71%
2 year high: 142
Gaotu Techedu Inc, formerly GSX Techedu Inc, is a China-based holding company principally involved in the provision of technology-driven education services. Through its subsidiaries, the Company is engaged in the provision of online K-12 after-school tutoring services. It also offers foreign language, professional and interest courses. The Company conducts its businesses in Mainland China.
Shares Outstanding 258.6M
Float 137.36M
Total Cash (mrq) 3.35B
Total Cash Per Share (mrq) 12.96
Total Debt (mrq) 153.04M
Book Value Per Share (mrq) 11.68
VNET: 4.125 -22.75%
52w: 3.51 - 18.86
(Bloomberg) -- Buyout firms CDH Investments and PAG are considering bids for US-listed Chinese data center company Vnet Group Inc., according to people familiar with the matter.
CDH and PAG have separately been exploring financing and deal structures for a potential offer, the people said, asking not to be identified because the matter is private. The investors could either bid on their own or form a consortium with other prospective bidders, the people said.
Considerations are ongoing and the companies could still decide against pursuing a transaction, they said. A representative for PAG declined to comment, while representatives for CDH and Vnet didn’t immediately respond to requests for comment.
Vnet last month received a preliminary non-binding takeover proposal from its founder and executive chairman Josh Sheng Chen at $8.20 per American depositary receipt in cash. Its board formed a special committee to evaluate the proposed transaction as well as other strategic alternatives, and is working with financial and legal advisers.
The approach followed a previous non-binding cash takeover in April from boutique Chinese advisory and private equity firm Hina Group and the Shanghai branch of Industrial Bank Co. to acquire Vnet’s shares for $8 per ADR.
Other companies considering bidding for Vnet include North Asia-focused investor MBK Partners, Bloomberg News has reported.
Founded in 1996, Vnet is a carrier-neutral data center services provider in China. It counts more than 50 data centers in more than 30 cities across China. The company formerly known as 21Vianet Group changed its name to Vnet Group last year.
CDH, an alternative investment fund manager focused on China, started in 2002 as a private equity platform and later expanded into other areas such as venture and growth capital, real assets, private credit, equities and private wealth management, according to its website. It had more than $26.6 billion of assets under management as of September last year.
PAG, an Asia-focused private equity firm backed by industry giant Blackstone Inc., counts about $50 billion in assets as of the end of June. It runs a variety of strategies including private equity, private debt, distressed, real estate and absolute return funds. The firm is considering delaying its planned initial public offering in Hong Kong amid market volatility, Bloomberg News has reported.
VNET: 4.125 -22.75%
52w: 3.51 - 18.86
(Bloomberg) -- Buyout firms CDH Investments and PAG are considering bids for US-listed Chinese data center company Vnet Group Inc., according to people familiar with the matter.
CDH and PAG have separately been exploring financing and deal structures for a potential offer, the people said, asking not to be identified because the matter is private. The investors could either bid on their own or form a consortium with other prospective bidders, the people said.
Considerations are ongoing and the companies could still decide against pursuing a transaction, they said. A representative for PAG declined to comment, while representatives for CDH and Vnet didn’t immediately respond to requests for comment.
Vnet last month received a preliminary non-binding takeover proposal from its founder and executive chairman Josh Sheng Chen at $8.20 per American depositary receipt in cash. Its board formed a special committee to evaluate the proposed transaction as well as other strategic alternatives, and is working with financial and legal advisers.
The approach followed a previous non-binding cash takeover in April from boutique Chinese advisory and private equity firm Hina Group and the Shanghai branch of Industrial Bank Co. to acquire Vnet’s shares for $8 per ADR.
Other companies considering bidding for Vnet include North Asia-focused investor MBK Partners, Bloomberg News has reported.
Founded in 1996, Vnet is a carrier-neutral data center services provider in China. It counts more than 50 data centers in more than 30 cities across China. The company formerly known as 21Vianet Group changed its name to Vnet Group last year.
CDH, an alternative investment fund manager focused on China, started in 2002 as a private equity platform and later expanded into other areas such as venture and growth capital, real assets, private credit, equities and private wealth management, according to its website. It had more than $26.6 billion of assets under management as of September last year.
PAG, an Asia-focused private equity firm backed by industry giant Blackstone Inc., counts about $50 billion in assets as of the end of June. It runs a variety of strategies including private equity, private debt, distressed, real estate and absolute return funds. The firm is considering delaying its planned initial public offering in Hong Kong amid market volatility, Bloomberg News has reported.
PRMO
NO DEBT!!
https://www.otcmarkets.com/otcapi/company/financial-report/342698/content
PRMO is Pink Current again!
https://www.otcmarkets.com/stock/PRMO/overview
NEW WEBSITE: https://www.promrestaurants.com
Prom Resources, Inc.
https://www.barchart.com/stocks/quotes/PRMO/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;HLMA(10,8);SMA(20);BBANDS(20,2);RSI(14,100);STOSL(14,3);SMACD(12,26,9);MOMENT(20);MFI(14,100);SMA(20)&sym=PRMO&grid=1&height=500&studyheight=100
Twitter:
$PRMO many are sleeping on
— Bill's Stocks and Thoughts (@billsstocks1) September 23, 2022
— Bill's Stocks and Thoughts (@billsstocks1) September 20, 2022
Vamos $PRMO https://t.co/5FiYwrYKfi
— FOX (@Jorgeemartineze) September 20, 2022
$SNMN strong support @ 0.0006$NWPN strong support @ 0.0005 with multiple news catalyst $PRMO 0.0003 holding nicely
— Savage (@KEdelbrock) September 13, 2022
$PRMO Everyone is Buying the Dip Right Now.Hoarding Shares,... https://t.co/mNJLOKlEGH
— Anita Mccormick (@AnitaMc26910087) September 13, 2022
Starting to load $PAOG. $PRMO has great chart potential on an 0004 break. Plus PRMO has the custodian that ran SPOM big back in the day
— Bill's Stocks and Thoughts (@billsstocks1) September 9, 2022
$prmo
— mike ferr (@ferrante821) September 10, 2022
The loading is off the hook
Sooner or later it will run
$VNUE After Christmas went from 0037 to 012 on almost nothing. A couple weeks later, it went to over 04 under worse fundamentals.$PRMO still haven't been filled by the whackers but I'm happy with 14MM
— Bill's Stocks and Thoughts (@billsstocks1) September 6, 2022
$PRMO
— DB Daytrades (@DB_Daytrades) September 6, 2022
Daily view of levels of interest. Need buyers to step in and break T5, I expect the day this happens we see immense volume step in and form T4 as a new based support moving forward. Alerts on watch. pic.twitter.com/FrOcPqeXzx
Ok let’s get $PRMO going soon 😎
— 🇵🇭PinayTigerTrades🗯 (@Brown_chickHB) September 1, 2022
$BYOC far from done. $PRMO chart indicating it could be next
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
Event based run with $CZNI vibes, possibly more. Volume precedes price on the chart. Also watching $PRMO (same custodian as the guy who ran $SPOM big back in 2020) for a trips run. Let's go $BYOC.
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
PRMO
NO DEBT!!
https://www.otcmarkets.com/otcapi/company/financial-report/342698/content
PRMO is Pink Current again!
https://www.otcmarkets.com/stock/PRMO/overview
NEW WEBSITE: https://www.promrestaurants.com
Prom Resources, Inc.
https://www.barchart.com/stocks/quotes/PRMO/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;HLMA(10,8);SMA(20);BBANDS(20,2);RSI(14,100);STOSL(14,3);SMACD(12,26,9);MOMENT(20);MFI(14,100);SMA(20)&sym=PRMO&grid=1&height=500&studyheight=100
Twitter:
$PRMO many are sleeping on
— Bill's Stocks and Thoughts (@billsstocks1) September 23, 2022
— Bill's Stocks and Thoughts (@billsstocks1) September 20, 2022
Vamos $PRMO https://t.co/5FiYwrYKfi
— FOX (@Jorgeemartineze) September 20, 2022
$SNMN strong support @ 0.0006$NWPN strong support @ 0.0005 with multiple news catalyst $PRMO 0.0003 holding nicely
— Savage (@KEdelbrock) September 13, 2022
$PRMO Everyone is Buying the Dip Right Now.Hoarding Shares,... https://t.co/mNJLOKlEGH
— Anita Mccormick (@AnitaMc26910087) September 13, 2022
Starting to load $PAOG. $PRMO has great chart potential on an 0004 break. Plus PRMO has the custodian that ran SPOM big back in the day
— Bill's Stocks and Thoughts (@billsstocks1) September 9, 2022
$prmo
— mike ferr (@ferrante821) September 10, 2022
The loading is off the hook
Sooner or later it will run
$VNUE After Christmas went from 0037 to 012 on almost nothing. A couple weeks later, it went to over 04 under worse fundamentals.$PRMO still haven't been filled by the whackers but I'm happy with 14MM
— Bill's Stocks and Thoughts (@billsstocks1) September 6, 2022
$PRMO
— DB Daytrades (@DB_Daytrades) September 6, 2022
Daily view of levels of interest. Need buyers to step in and break T5, I expect the day this happens we see immense volume step in and form T4 as a new based support moving forward. Alerts on watch. pic.twitter.com/FrOcPqeXzx
Ok let’s get $PRMO going soon 😎
— 🇵🇭PinayTigerTrades🗯 (@Brown_chickHB) September 1, 2022
$BYOC far from done. $PRMO chart indicating it could be next
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
Event based run with $CZNI vibes, possibly more. Volume precedes price on the chart. Also watching $PRMO (same custodian as the guy who ran $SPOM big back in 2020) for a trips run. Let's go $BYOC.
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
PRMO
NO DEBT!!
https://www.otcmarkets.com/otcapi/company/financial-report/342698/content
PRMO is Pink Current again!
https://www.otcmarkets.com/stock/PRMO/overview
NEW WEBSITE: https://www.promrestaurants.com
Prom Resources, Inc.
https://www.barchart.com/stocks/quotes/PRMO/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;HLMA(10,8);SMA(20);BBANDS(20,2);RSI(14,100);STOSL(14,3);SMACD(12,26,9);MOMENT(20);MFI(14,100);SMA(20)&sym=PRMO&grid=1&height=500&studyheight=100
Twitter:
$PRMO many are sleeping on
— Bill's Stocks and Thoughts (@billsstocks1) September 23, 2022
— Bill's Stocks and Thoughts (@billsstocks1) September 20, 2022
Vamos $PRMO https://t.co/5FiYwrYKfi
— FOX (@Jorgeemartineze) September 20, 2022
$SNMN strong support @ 0.0006$NWPN strong support @ 0.0005 with multiple news catalyst $PRMO 0.0003 holding nicely
— Savage (@KEdelbrock) September 13, 2022
$PRMO Everyone is Buying the Dip Right Now.Hoarding Shares,... https://t.co/mNJLOKlEGH
— Anita Mccormick (@AnitaMc26910087) September 13, 2022
Starting to load $PAOG. $PRMO has great chart potential on an 0004 break. Plus PRMO has the custodian that ran SPOM big back in the day
— Bill's Stocks and Thoughts (@billsstocks1) September 9, 2022
$prmo
— mike ferr (@ferrante821) September 10, 2022
The loading is off the hook
Sooner or later it will run
$VNUE After Christmas went from 0037 to 012 on almost nothing. A couple weeks later, it went to over 04 under worse fundamentals.$PRMO still haven't been filled by the whackers but I'm happy with 14MM
— Bill's Stocks and Thoughts (@billsstocks1) September 6, 2022
$PRMO
— DB Daytrades (@DB_Daytrades) September 6, 2022
Daily view of levels of interest. Need buyers to step in and break T5, I expect the day this happens we see immense volume step in and form T4 as a new based support moving forward. Alerts on watch. pic.twitter.com/FrOcPqeXzx
Ok let’s get $PRMO going soon 😎
— 🇵🇭PinayTigerTrades🗯 (@Brown_chickHB) September 1, 2022
$BYOC far from done. $PRMO chart indicating it could be next
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
Event based run with $CZNI vibes, possibly more. Volume precedes price on the chart. Also watching $PRMO (same custodian as the guy who ran $SPOM big back in 2020) for a trips run. Let's go $BYOC.
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
PRMO
NO DEBT!!
https://www.otcmarkets.com/otcapi/company/financial-report/342698/content
PRMO is Pink Current again!
https://www.otcmarkets.com/stock/PRMO/overview
NEW WEBSITE: https://www.promrestaurants.com
Prom Resources, Inc.
https://www.barchart.com/stocks/quotes/PRMO/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;HLMA(10,8);SMA(20);BBANDS(20,2);RSI(14,100);STOSL(14,3);SMACD(12,26,9);MOMENT(20);MFI(14,100);SMA(20)&sym=PRMO&grid=1&height=500&studyheight=100
Twitter:
$PRMO many are sleeping on
— Bill's Stocks and Thoughts (@billsstocks1) September 23, 2022
— Bill's Stocks and Thoughts (@billsstocks1) September 20, 2022
Vamos $PRMO https://t.co/5FiYwrYKfi
— FOX (@Jorgeemartineze) September 20, 2022
$SNMN strong support @ 0.0006$NWPN strong support @ 0.0005 with multiple news catalyst $PRMO 0.0003 holding nicely
— Savage (@KEdelbrock) September 13, 2022
$PRMO Everyone is Buying the Dip Right Now.Hoarding Shares,... https://t.co/mNJLOKlEGH
— Anita Mccormick (@AnitaMc26910087) September 13, 2022
Starting to load $PAOG. $PRMO has great chart potential on an 0004 break. Plus PRMO has the custodian that ran SPOM big back in the day
— Bill's Stocks and Thoughts (@billsstocks1) September 9, 2022
$prmo
— mike ferr (@ferrante821) September 10, 2022
The loading is off the hook
Sooner or later it will run
$VNUE After Christmas went from 0037 to 012 on almost nothing. A couple weeks later, it went to over 04 under worse fundamentals.$PRMO still haven't been filled by the whackers but I'm happy with 14MM
— Bill's Stocks and Thoughts (@billsstocks1) September 6, 2022
$PRMO
— DB Daytrades (@DB_Daytrades) September 6, 2022
Daily view of levels of interest. Need buyers to step in and break T5, I expect the day this happens we see immense volume step in and form T4 as a new based support moving forward. Alerts on watch. pic.twitter.com/FrOcPqeXzx
Ok let’s get $PRMO going soon 😎
— 🇵🇭PinayTigerTrades🗯 (@Brown_chickHB) September 1, 2022
$BYOC far from done. $PRMO chart indicating it could be next
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
Event based run with $CZNI vibes, possibly more. Volume precedes price on the chart. Also watching $PRMO (same custodian as the guy who ran $SPOM big back in 2020) for a trips run. Let's go $BYOC.
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
TAOP: 0.7400 +0.07 (+10.45%)
52w: 0.55 - 3.58
HONG KONG, Oct. 18, 2022 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company" or "TAOP") today announced that its wholly owned subsidiary, Taoping Digital Tech. (Jiangsu) Co., Ltd. entered into a three-year strategic cooperation agreement with Jiangsu SuLiXin Cultural Creative Group Co., Ltd. ("SuLiXin"). Under the agreement, SuLiXin will purchase display terminals and services from Taoping, with the two companies also agreeing to jointly develop larger scale digital multimedia exhibition hall projects across China. Specifically, SuLiXin plans to purchase at least RMB 30 million (US$4.2 million) of equipment from Taoping during the term of the agreement.
According to the agreement, Taoping will be recognized as a strategic partner to SuLiXin and the main supplier of DLP, LCD, LED and other large display screens required for its larger scale, digital multimedia exhibition hall projects. Taoping has agreed to leverage the channel advantages of its proprietary city partners network to actively help promote the development of SuLiXin's various other cultural exhibition hall project businesses in the national market, especially in East China.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "Taoping and SuliXin know each other well, having successfully worked together previously on other projects in Jiangsu Province. We are excited to be formally expanding our relationship and view this agreement as an important milestone for both companies, where we can build on our respective advantages to our mutual benefit. As the earliest enterprise involved in large-screen display manufacturing and system integration in China, Taoping's proprietary internally developed large-screen displays have been welcomed by customers for a long time for their best in class performance and customization. With more than 1,000 successful installations, Taoping has an excellent track record in a wide range of customer environments, ranging from supermarkets, office buildings and media boards, to hospitals, electronics, airports and more."
Mr. Lin Jianghuai continued: "Relying on our national channel of city partners and the leading intelligent cloud platform as a solid platform to build on, we believe that the Company's smart displays can be installed more quickly in digital multimedia exhibition hall projects giving us an important advantage as we look to empower customers by promoting digital commercial display technology efficiently and helping multimedia exhibition halls move more quickly to digitalization, while continuing to grow our profitable revenue streams."
About SuLiXin:
As a "famous trademark of Jiangsu Province" enterprise, SuLiXin has the integrated license of national exhibition hall design and construction, national exhibition hall engineering enterprise license, Jiangsu building decoration engineering professional contracting license and other qualifications. SuLiXin has focused on the design and construction of cultural and creative and scientific exhibition halls, with rich experience in creative design and construction in cultural museums, memorial halls, theme halls, enterprise halls, cultural theme parks, and more.
About Taoping Inc.
Taoping Inc. (NASDAQ: TAOP) is a blockchain technology and smart cloud services provider. The Company is dedicated to the research and application of blockchain technology and digital assets, and continues to improve computing power and create value for the encrypted digital currency industry. Relying on its self-developed smart cloud platform, TAOP also provides solutions and cloud services to industries such as smart community, new media and artificial intelligence. To learn more, please visit http://www.taop.com/.
TAOP: 0.7400 +0.07 (+10.45%)
52w: 0.55 - 3.58
HONG KONG, Oct. 18, 2022 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company" or "TAOP") today announced that its wholly owned subsidiary, Taoping Digital Tech. (Jiangsu) Co., Ltd. entered into a three-year strategic cooperation agreement with Jiangsu SuLiXin Cultural Creative Group Co., Ltd. ("SuLiXin"). Under the agreement, SuLiXin will purchase display terminals and services from Taoping, with the two companies also agreeing to jointly develop larger scale digital multimedia exhibition hall projects across China. Specifically, SuLiXin plans to purchase at least RMB 30 million (US$4.2 million) of equipment from Taoping during the term of the agreement.
According to the agreement, Taoping will be recognized as a strategic partner to SuLiXin and the main supplier of DLP, LCD, LED and other large display screens required for its larger scale, digital multimedia exhibition hall projects. Taoping has agreed to leverage the channel advantages of its proprietary city partners network to actively help promote the development of SuLiXin's various other cultural exhibition hall project businesses in the national market, especially in East China.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "Taoping and SuliXin know each other well, having successfully worked together previously on other projects in Jiangsu Province. We are excited to be formally expanding our relationship and view this agreement as an important milestone for both companies, where we can build on our respective advantages to our mutual benefit. As the earliest enterprise involved in large-screen display manufacturing and system integration in China, Taoping's proprietary internally developed large-screen displays have been welcomed by customers for a long time for their best in class performance and customization. With more than 1,000 successful installations, Taoping has an excellent track record in a wide range of customer environments, ranging from supermarkets, office buildings and media boards, to hospitals, electronics, airports and more."
Mr. Lin Jianghuai continued: "Relying on our national channel of city partners and the leading intelligent cloud platform as a solid platform to build on, we believe that the Company's smart displays can be installed more quickly in digital multimedia exhibition hall projects giving us an important advantage as we look to empower customers by promoting digital commercial display technology efficiently and helping multimedia exhibition halls move more quickly to digitalization, while continuing to grow our profitable revenue streams."
About SuLiXin:
As a "famous trademark of Jiangsu Province" enterprise, SuLiXin has the integrated license of national exhibition hall design and construction, national exhibition hall engineering enterprise license, Jiangsu building decoration engineering professional contracting license and other qualifications. SuLiXin has focused on the design and construction of cultural and creative and scientific exhibition halls, with rich experience in creative design and construction in cultural museums, memorial halls, theme halls, enterprise halls, cultural theme parks, and more.
About Taoping Inc.
Taoping Inc. (NASDAQ: TAOP) is a blockchain technology and smart cloud services provider. The Company is dedicated to the research and application of blockchain technology and digital assets, and continues to improve computing power and create value for the encrypted digital currency industry. Relying on its self-developed smart cloud platform, TAOP also provides solutions and cloud services to industries such as smart community, new media and artificial intelligence. To learn more, please visit http://www.taop.com/.
VNET
premarket: 6.35 + 0.97 (+18.03%)
(Bloomberg) -- Buyout firms CDH Investments and PAG are considering bids for US-listed Chinese data center company Vnet Group Inc., according to people familiar with the matter.
CDH and PAG have separately been exploring financing and deal structures for a potential offer, the people said, asking not to be identified because the matter is private. The investors could either bid on their own or form a consortium with other prospective bidders, the people said.
Considerations are ongoing and the companies could still decide against pursuing a transaction, they said. A representative for PAG declined to comment, while representatives for CDH and Vnet didn’t immediately respond to requests for comment.
Vnet last month received a preliminary non-binding takeover proposal from its founder and executive chairman Josh Sheng Chen at $8.20 per American depositary receipt in cash. Its board formed a special committee to evaluate the proposed transaction as well as other strategic alternatives, and is working with financial and legal advisers.
The approach followed a previous non-binding cash takeover in April from boutique Chinese advisory and private equity firm Hina Group and the Shanghai branch of Industrial Bank Co. to acquire Vnet’s shares for $8 per ADR.
Other companies considering bidding for Vnet include North Asia-focused investor MBK Partners, Bloomberg News has reported.
Shares in Vnet jumped as much as 18% in pre-market trading. They had declined 40% this year as of Monday’s close, valuing the company at about $796 million.
Founded in 1996, Vnet is a carrier-neutral data center services provider in China. It counts more than 50 data centers in more than 30 cities across China. The company formerly known as 21Vianet Group changed its name to Vnet Group last year.
CDH, an alternative investment fund manager focused on China, started in 2002 as a private equity platform and later expanded into other areas such as venture and growth capital, real assets, private credit, equities and private wealth management, according to its website. It had more than $26.6 billion of assets under management as of September last year.
PAG, an Asia-focused private equity firm backed by industry giant Blackstone Inc., counts about $50 billion in assets as of the end of June. It runs a variety of strategies including private equity, private debt, distressed, real estate and absolute return funds. The firm is considering delaying its planned initial public offering in Hong Kong amid market volatility, Bloomberg News has reported.
VNET
premarket: 6.35 + 0.97 (+18.03%)
(Bloomberg) -- Buyout firms CDH Investments and PAG are considering bids for US-listed Chinese data center company Vnet Group Inc., according to people familiar with the matter.
CDH and PAG have separately been exploring financing and deal structures for a potential offer, the people said, asking not to be identified because the matter is private. The investors could either bid on their own or form a consortium with other prospective bidders, the people said.
Considerations are ongoing and the companies could still decide against pursuing a transaction, they said. A representative for PAG declined to comment, while representatives for CDH and Vnet didn’t immediately respond to requests for comment.
Vnet last month received a preliminary non-binding takeover proposal from its founder and executive chairman Josh Sheng Chen at $8.20 per American depositary receipt in cash. Its board formed a special committee to evaluate the proposed transaction as well as other strategic alternatives, and is working with financial and legal advisers.
The approach followed a previous non-binding cash takeover in April from boutique Chinese advisory and private equity firm Hina Group and the Shanghai branch of Industrial Bank Co. to acquire Vnet’s shares for $8 per ADR.
Other companies considering bidding for Vnet include North Asia-focused investor MBK Partners, Bloomberg News has reported.
Shares in Vnet jumped as much as 18% in pre-market trading. They had declined 40% this year as of Monday’s close, valuing the company at about $796 million.
Founded in 1996, Vnet is a carrier-neutral data center services provider in China. It counts more than 50 data centers in more than 30 cities across China. The company formerly known as 21Vianet Group changed its name to Vnet Group last year.
CDH, an alternative investment fund manager focused on China, started in 2002 as a private equity platform and later expanded into other areas such as venture and growth capital, real assets, private credit, equities and private wealth management, according to its website. It had more than $26.6 billion of assets under management as of September last year.
PAG, an Asia-focused private equity firm backed by industry giant Blackstone Inc., counts about $50 billion in assets as of the end of June. It runs a variety of strategies including private equity, private debt, distressed, real estate and absolute return funds. The firm is considering delaying its planned initial public offering in Hong Kong amid market volatility, Bloomberg News has reported.
jaguar Health, Inc. (JAGX) 0.1407-0.0055 (-3.76%)
Pre-Market: $0.1795 (+27.58%)
MVID, a rare congenital diarrheal disorder (CDD) condition, is a life-threatening autosomal recessive disease that affects newborns and children and leads to significant morbidity and mortality from intestinal failure, including severe secretory diarrhea
Presentation expected in December 2022 of initial results of an investigator-initiated proof-of-concept trial of crofelemer for CDD and short bowel syndrome (SBS) with intestinal failure, supporting the potential for expanded patient access to crofelemer in 2023 in Europe
Pravin Chaturvedi, PhD, Jaguar's Chief Scientific Officer and Chair of the Scientific Advisory Board, Receives First Boston Biotechnology Summit Lifetime Achievement Award
SAN FRANCISCO, CA / ACCESSWIRE / October 17, 2022 / Jaguar Health (NASDAQ:JAGX) and Napo Therapeutics, the Italian corporation established by Jaguar Health in Italy in 2021 that focuses on development and commercialization of crofelemer in orphan and rare diseases, thus expanding access to crofelemer to patients in Europe, today announced that the European Commission has adopted the decision to grant Orphan Drug Designation (ODD) for crofelemer for the indication of microvillus inclusion disease (MVID), a rare congenital diarrheal disorder (CDD) condition, in the European Union following review of the ODD application Napo Therapeutics submitted to the European Medicines Agency (EMA) in May 2022.
"This is a very welcome development for crofelemer, a new molecular entity that has been granted two orphan designations by the EMA in less than one year, as crofelemer received ODD for short bowel syndrome (SBS) from the EMA in December 2021," said Massimo Mineo, CEO of Napo Therapeutics. "The recognition of ODD in Europe for crofelemer for MVID is a key Napo Therapeutics milestone under the company's exclusive crofelemer license agreement with Jaguar, and receipt of this new ODD supports some specific regulatory pathways for this serious form of CDD, which remains a significant unmet medical need, especially in pediatric patients."
"CDDs are a group of inherited chronic enteropathies characterized by heterogeneous etiology, and each type of CDD is thus a different disease with a different pathogenetic mechanism," said Martire Particco, MD, Chief Medical Officer of Napo Therapeutics. "MVID is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to significant morbidity and even death from severe secretory diarrhea."
CDD and SBS patients are both subject to intestinal failure, often requiring parenteral nutrition up to 7 days a week, and the immense associated morbidity, mortality, and medical expense. CDD and SBS patients also share a primary common symptom: chronic diarrhea, and therefore associated sequelae from diarrhea, including significant dehydration, metabolic acidosis or alkalosis and malnutrition, and other secondary symptoms, and these symptoms emerge either early or late, and many times become life-threatening.
Napo Therapeutics' mission is to provide access to Jaguar Health's proprietary first-in-class plant-based medicine crofelemer in Europe to address such significant rare disease indications. The company's initial focus is on the clinical development and registration in Europe of crofelemer for short bowel syndrome with intestinal failure (SBS-IF) and subsequently for CDD.
Jaguar is currently supporting an investigator-initiated proof-of-concept study of crofelemer in patients with SBS or CDD with intestinal failure, with a planned endpoint of reduction of requirement of weekly volume of parenteral nutrition. The investigator is targeting a presentation in December 2022 of initial results from the study at a global GI conference in Dubai. In accordance with the guidelines of specific EU countries, publications of such data could support early patient access of crofelemer for SBS or CDD with intestinal failure by mid-2023 through programs in Europe for these devastating diseases for which there is a significant unmet medical need.
Sponsors who obtain ODD for their drug can benefit from Scientific Advice from the EMA for clinical trials for the orphan indication and receive market exclusivity for a period of ten years once the medicine is approved for commercialization.
On October 14, 2022, Pravin Chaturvedi, PhD, Jaguar's Chief Scientific Officer and Chair of the Scientific Advisory Board, received a First Boston Biotechnology Summit Lifetime Achievement Award during the Boston Biotechnology Summit. "We congratulate Dr. Chaturvedi on this wonderful and very well-deserved accomplishment! During his impressive 30+ year career in the pharmaceutical industry, Dr. Chaturvedi has developed and brought to market seven pharmaceutical products in the U.S., and his list of accomplishments includes designing the successful Phase 3 ADVENT trial of crofelemer that resulted in approval of the drug in the U.S., now marketed under the name Mytesi®, for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy," said Lisa Conte, Jaguar's president and CEO.
The Boston Biotechnology Summit is an exclusive, Trans-Atlantic bridge designed to foster innovative synergies between biotech and pharma companies, healthcare-focused cities, regional clusters and institutional, philanthropic and strategic investors. The Summit's intent is to spark projects, their financing, and strategic deals to solve unmet medical needs to improve patient lives globally.
jaguar Health, Inc. (JAGX) 0.1407-0.0055 (-3.76%)
Pre-Market: $0.1795 (+27.58%)
MVID, a rare congenital diarrheal disorder (CDD) condition, is a life-threatening autosomal recessive disease that affects newborns and children and leads to significant morbidity and mortality from intestinal failure, including severe secretory diarrhea
Presentation expected in December 2022 of initial results of an investigator-initiated proof-of-concept trial of crofelemer for CDD and short bowel syndrome (SBS) with intestinal failure, supporting the potential for expanded patient access to crofelemer in 2023 in Europe
Pravin Chaturvedi, PhD, Jaguar's Chief Scientific Officer and Chair of the Scientific Advisory Board, Receives First Boston Biotechnology Summit Lifetime Achievement Award
SAN FRANCISCO, CA / ACCESSWIRE / October 17, 2022 / Jaguar Health (NASDAQ:JAGX) and Napo Therapeutics, the Italian corporation established by Jaguar Health in Italy in 2021 that focuses on development and commercialization of crofelemer in orphan and rare diseases, thus expanding access to crofelemer to patients in Europe, today announced that the European Commission has adopted the decision to grant Orphan Drug Designation (ODD) for crofelemer for the indication of microvillus inclusion disease (MVID), a rare congenital diarrheal disorder (CDD) condition, in the European Union following review of the ODD application Napo Therapeutics submitted to the European Medicines Agency (EMA) in May 2022.
"This is a very welcome development for crofelemer, a new molecular entity that has been granted two orphan designations by the EMA in less than one year, as crofelemer received ODD for short bowel syndrome (SBS) from the EMA in December 2021," said Massimo Mineo, CEO of Napo Therapeutics. "The recognition of ODD in Europe for crofelemer for MVID is a key Napo Therapeutics milestone under the company's exclusive crofelemer license agreement with Jaguar, and receipt of this new ODD supports some specific regulatory pathways for this serious form of CDD, which remains a significant unmet medical need, especially in pediatric patients."
"CDDs are a group of inherited chronic enteropathies characterized by heterogeneous etiology, and each type of CDD is thus a different disease with a different pathogenetic mechanism," said Martire Particco, MD, Chief Medical Officer of Napo Therapeutics. "MVID is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to significant morbidity and even death from severe secretory diarrhea."
CDD and SBS patients are both subject to intestinal failure, often requiring parenteral nutrition up to 7 days a week, and the immense associated morbidity, mortality, and medical expense. CDD and SBS patients also share a primary common symptom: chronic diarrhea, and therefore associated sequelae from diarrhea, including significant dehydration, metabolic acidosis or alkalosis and malnutrition, and other secondary symptoms, and these symptoms emerge either early or late, and many times become life-threatening.
Napo Therapeutics' mission is to provide access to Jaguar Health's proprietary first-in-class plant-based medicine crofelemer in Europe to address such significant rare disease indications. The company's initial focus is on the clinical development and registration in Europe of crofelemer for short bowel syndrome with intestinal failure (SBS-IF) and subsequently for CDD.
Jaguar is currently supporting an investigator-initiated proof-of-concept study of crofelemer in patients with SBS or CDD with intestinal failure, with a planned endpoint of reduction of requirement of weekly volume of parenteral nutrition. The investigator is targeting a presentation in December 2022 of initial results from the study at a global GI conference in Dubai. In accordance with the guidelines of specific EU countries, publications of such data could support early patient access of crofelemer for SBS or CDD with intestinal failure by mid-2023 through programs in Europe for these devastating diseases for which there is a significant unmet medical need.
Sponsors who obtain ODD for their drug can benefit from Scientific Advice from the EMA for clinical trials for the orphan indication and receive market exclusivity for a period of ten years once the medicine is approved for commercialization.
On October 14, 2022, Pravin Chaturvedi, PhD, Jaguar's Chief Scientific Officer and Chair of the Scientific Advisory Board, received a First Boston Biotechnology Summit Lifetime Achievement Award during the Boston Biotechnology Summit. "We congratulate Dr. Chaturvedi on this wonderful and very well-deserved accomplishment! During his impressive 30+ year career in the pharmaceutical industry, Dr. Chaturvedi has developed and brought to market seven pharmaceutical products in the U.S., and his list of accomplishments includes designing the successful Phase 3 ADVENT trial of crofelemer that resulted in approval of the drug in the U.S., now marketed under the name Mytesi®, for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy," said Lisa Conte, Jaguar's president and CEO.
The Boston Biotechnology Summit is an exclusive, Trans-Atlantic bridge designed to foster innovative synergies between biotech and pharma companies, healthcare-focused cities, regional clusters and institutional, philanthropic and strategic investors. The Summit's intent is to spark projects, their financing, and strategic deals to solve unmet medical needs to improve patient lives globally.
Opgen (OPGN): 0.2399 + 3.58%
52w: 0.23 – 2.25
Were down more than 50% this month
Oct 11, 2022 0.2300 0.2399 0.2000 0.2301 0.2301 642,384
Oct 10, 2022 0.2580 0.2580 0.2300 0.2320 0.2320 316,400
Oct 07, 2022 0.2500 0.2800 0.2430 0.2510 0.2510 401,200
Oct 06, 2022 0.2800 0.3000 0.2620 0.2680 0.2680 432,300
Oct 05, 2022 0.3190 0.3190 0.2750 0.2800 0.2800 189,600
Oct 04, 2022 0.3110 0.3200 0.2900 0.3060 0.3060 255,200
Oct 03, 2022 0.2970 0.3300 0.2900 0.3100 0.3100 625,000
Sep 30, 2022 0.3400 0.3570 0.2700 0.2860 0.2860 1,446,300
Sep 29, 2022 0.3720 0.3940 0.3710 0.3770 0.3770 116,700
Sep 28, 2022 0.3800 0.3930 0.3790 0.3800 0.3800 81,900
Sep 27, 2022 0.3800 0.4000 0.3720 0.3790 0.3790 60,000
Sep 26, 2022 0.4100 0.4100 0.3900 0.3940 0.3940 48,000
Sep 23, 2022 0.4000 0.4200 0.3700 0.3870 0.3870 251,700
Sep 22, 2022 0.4350 0.4480 0.4030 0.4160 0.4160 119,900
Sep 21, 2022 0.4120 0.4400 0.4100 0.4240 0.4240 120,700
Sep 20, 2022 0.4400 0.4470 0.4160 0.4180 0.4180 193,700
Sep 19, 2022 0.4130 0.4390 0.3980 0.4210 0.4210 145,500
Sep 16, 2022 0.4100 0.4190 0.3900 0.4190 0.4190 220,700
Sep 15, 2022 0.4410 0.4450 0.4150 0.4300 0.4300 152,600
Sep 14, 2022 0.4600 0.4600 0.4250 0.4320 0.4320 223,900
Sep 13, 2022 0.4660 0.4800 0.4360 0.4570 0.4570 629,600
Opgen (OPGN): 0.2399 + 3.58%
52w: 0.23 – 2.25
Were down more than 50% this month
Oct 11, 2022 0.2300 0.2399 0.2000 0.2301 0.2301 642,384
Oct 10, 2022 0.2580 0.2580 0.2300 0.2320 0.2320 316,400
Oct 07, 2022 0.2500 0.2800 0.2430 0.2510 0.2510 401,200
Oct 06, 2022 0.2800 0.3000 0.2620 0.2680 0.2680 432,300
Oct 05, 2022 0.3190 0.3190 0.2750 0.2800 0.2800 189,600
Oct 04, 2022 0.3110 0.3200 0.2900 0.3060 0.3060 255,200
Oct 03, 2022 0.2970 0.3300 0.2900 0.3100 0.3100 625,000
Sep 30, 2022 0.3400 0.3570 0.2700 0.2860 0.2860 1,446,300
Sep 29, 2022 0.3720 0.3940 0.3710 0.3770 0.3770 116,700
Sep 28, 2022 0.3800 0.3930 0.3790 0.3800 0.3800 81,900
Sep 27, 2022 0.3800 0.4000 0.3720 0.3790 0.3790 60,000
Sep 26, 2022 0.4100 0.4100 0.3900 0.3940 0.3940 48,000
Sep 23, 2022 0.4000 0.4200 0.3700 0.3870 0.3870 251,700
Sep 22, 2022 0.4350 0.4480 0.4030 0.4160 0.4160 119,900
Sep 21, 2022 0.4120 0.4400 0.4100 0.4240 0.4240 120,700
Sep 20, 2022 0.4400 0.4470 0.4160 0.4180 0.4180 193,700
Sep 19, 2022 0.4130 0.4390 0.3980 0.4210 0.4210 145,500
Sep 16, 2022 0.4100 0.4190 0.3900 0.4190 0.4190 220,700
Sep 15, 2022 0.4410 0.4450 0.4150 0.4300 0.4300 152,600
Sep 14, 2022 0.4600 0.4600 0.4250 0.4320 0.4320 223,900
Sep 13, 2022 0.4660 0.4800 0.4360 0.4570 0.4570 629,600
Opgen (OPGN): 0.2399 + 3.58%
52w: 0.23 – 2.25
OpGen, Inc. is a precision medicine company that uses molecular diagnostics and informatics to combat infectious disease. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes the Curetis Unyvero System and multiplex syndromic panels, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb using next generation sequencing (NGS) technology and Artificial intelligence (AI) powered bioinformatics solutions for antibiotic response prediction, as well as the Curetis CE vitro diagnostic (IVD) marked polymerase chain reaction (PCR) based severe acute respiratory syndrome (SARS) CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.
ROCKVILLE, Md., Oct. 03, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that it has closed its previously announced registered direct offering with a single institutional investor for the purchase and sale of 9,660,000 shares of the Company’s common stock (or common stock equivalents), 33,810 shares of Series C mirroring preferred stock (“Series C Preferred”) and, in a concurrent private placement, unregistered warrants to purchase up to an aggregate of 9,660,000 shares of common stock, at a purchase price of $0.35 per share of common stock
ROCKVILLE, Md., Oct. 03, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced its successful completion of patient enrollment for its clinical trial for the Unyvero Urinary Tract Infection (UTI) Panel.
OpGen’s Unyvero UTI Panel tests for a broad range of bacterial and fungal pathogens as well as antimicrobial resistance markers directly from native urine specimens. OpGen had recently added a fourth study site in the U.S. to optimize enrollment for different urine sample types to be included in the study, which enabled successful collection of over 1,800 urine samples.
“We’re excited to have completed sample enrollment with our four clinical trial site partners as planned. After having reached our goal of at least 1,500 prospective samples as recommended by applicable FDA guidance, our team will now conclude reference testing in preparation of unblinding and final data readout, and we will start working towards a subsequent FDA submission package,” said Johannes Bacher, Chief Operating Officer of OpGen and Managing Director of its German based subsidiary Curetis GmbH.
Given the complexity and comprehensive nature of the data sets, OpGen expects to conclude data analysis in the next couple of months. Unblinded data for each patient sample will comprise Unyvero UTI Panel results, standard of care microbiology from the clinical trial sites, as well as additional standardized central microbiology data from a reference laboratory.
Opgen (OPGN): 0.2399 + 3.58%
52w: 0.23 – 2.25
OpGen, Inc. is a precision medicine company that uses molecular diagnostics and informatics to combat infectious disease. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes the Curetis Unyvero System and multiplex syndromic panels, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb using next generation sequencing (NGS) technology and Artificial intelligence (AI) powered bioinformatics solutions for antibiotic response prediction, as well as the Curetis CE vitro diagnostic (IVD) marked polymerase chain reaction (PCR) based severe acute respiratory syndrome (SARS) CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.
ROCKVILLE, Md., Oct. 03, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that it has closed its previously announced registered direct offering with a single institutional investor for the purchase and sale of 9,660,000 shares of the Company’s common stock (or common stock equivalents), 33,810 shares of Series C mirroring preferred stock (“Series C Preferred”) and, in a concurrent private placement, unregistered warrants to purchase up to an aggregate of 9,660,000 shares of common stock, at a purchase price of $0.35 per share of common stock
ROCKVILLE, Md., Oct. 03, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced its successful completion of patient enrollment for its clinical trial for the Unyvero Urinary Tract Infection (UTI) Panel.
OpGen’s Unyvero UTI Panel tests for a broad range of bacterial and fungal pathogens as well as antimicrobial resistance markers directly from native urine specimens. OpGen had recently added a fourth study site in the U.S. to optimize enrollment for different urine sample types to be included in the study, which enabled successful collection of over 1,800 urine samples.
“We’re excited to have completed sample enrollment with our four clinical trial site partners as planned. After having reached our goal of at least 1,500 prospective samples as recommended by applicable FDA guidance, our team will now conclude reference testing in preparation of unblinding and final data readout, and we will start working towards a subsequent FDA submission package,” said Johannes Bacher, Chief Operating Officer of OpGen and Managing Director of its German based subsidiary Curetis GmbH.
Given the complexity and comprehensive nature of the data sets, OpGen expects to conclude data analysis in the next couple of months. Unblinded data for each patient sample will comprise Unyvero UTI Panel results, standard of care microbiology from the clinical trial sites, as well as additional standardized central microbiology data from a reference laboratory.
RESHAPE LIFESCIENCES (RSLS) 0,34 +11,44%
52w: 0.28 - 3.28
ReShape Lifesciences Inc. is a weight-loss solutions company. The Company is focused on offering an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. Its reshapecare virtual health coaching program is a reimbursed telehealth weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients. Its ReShape Marketplace is an online store, that provides a line of products for bariatric patients. Its ReShape Optimize supplement options include multivitamins, probiotics, calcium, vitamin D, protein and other therapeutic offerings to optimize health. Its ReShape Vest is an investigational, minimally invasive, laparoscopically implanted medical device.
RESHAPE LIFESCIENCES (RSLS) 0,34 +11,44%
52w: 0.28 - 3.28
ReShape Lifesciences Inc. is a weight-loss solutions company. The Company is focused on offering an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. Its reshapecare virtual health coaching program is a reimbursed telehealth weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients. Its ReShape Marketplace is an online store, that provides a line of products for bariatric patients. Its ReShape Optimize supplement options include multivitamins, probiotics, calcium, vitamin D, protein and other therapeutic offerings to optimize health. Its ReShape Vest is an investigational, minimally invasive, laparoscopically implanted medical device.
VNET GROUP INC. (VNET) : 4.48
52w: 3.51 - 19.66
VNET Group Inc, formerly 21Vianet Group Inc, is a carrier-neutral Internet data center services provider. The Company hosts its customers' servers and networking equipment and provides interconnectivity. The Company also provides managed network services to enable customers to deliver data across the Internet through its data transmission network and smart routing technology. The Company provides value-added services, such as content delivery network services, virtual private network services and last-mile wired broadband services. It offers public cloud services, private cloud and hybrid services. The Company also offers container-based data center service. The Company's service offerings include hosting and related services, and managed network services. The Company provides hosting and related services to house servers and networking equipment in its data centers and connects them through its data transmission network, and offers other hosting related value-added services.
Sept 13 (Reuters) - VNET Group Inc :
* VNET ANNOUNCES RECEIPT OF PRELIMINARY NON-BINDING PROPOSAL
TO
ACQUIRE ALL OF ITS SHARES AND FORMATION OF SPECIAL COMMITTEE TO
REVIEW THE PROPOSAL
* VNET GROUP INC - RECEIVED A PRELIMINARY NON-BINDING
PROPOSAL
LETTER FROM JOSH SHENG CHEN, FOUNDER OF COMPANY
* VNET GROUP INC - PROPOSAL TO ACQUIRE ALL OF OUTSTANDING
ORDINARY SHARES OF COMPANY FOR $8.20 IN CASH PER AMERICAN DEPOSITARY SHARE
* VNET GROUP INC - FORMED COMMITTEE TO EVALUATE AND CONSIDER
PROPOSED TRANSACTION AS WELL AS OTHER POTENTIAL STRATEGIC
ALTERNATIVES
VNET GROUP INC. (VNET) : 4.48
52w: 3.51 - 19.66
VNET Group Inc, formerly 21Vianet Group Inc, is a carrier-neutral Internet data center services provider. The Company hosts its customers' servers and networking equipment and provides interconnectivity. The Company also provides managed network services to enable customers to deliver data across the Internet through its data transmission network and smart routing technology. The Company provides value-added services, such as content delivery network services, virtual private network services and last-mile wired broadband services. It offers public cloud services, private cloud and hybrid services. The Company also offers container-based data center service. The Company's service offerings include hosting and related services, and managed network services. The Company provides hosting and related services to house servers and networking equipment in its data centers and connects them through its data transmission network, and offers other hosting related value-added services.
Sept 13 (Reuters) - VNET Group Inc :
* VNET ANNOUNCES RECEIPT OF PRELIMINARY NON-BINDING PROPOSAL
TO
ACQUIRE ALL OF ITS SHARES AND FORMATION OF SPECIAL COMMITTEE TO
REVIEW THE PROPOSAL
* VNET GROUP INC - RECEIVED A PRELIMINARY NON-BINDING
PROPOSAL
LETTER FROM JOSH SHENG CHEN, FOUNDER OF COMPANY
* VNET GROUP INC - PROPOSAL TO ACQUIRE ALL OF OUTSTANDING
ORDINARY SHARES OF COMPANY FOR $8.20 IN CASH PER AMERICAN DEPOSITARY SHARE
* VNET GROUP INC - FORMED COMMITTEE TO EVALUATE AND CONSIDER
PROPOSED TRANSACTION AS WELL AS OTHER POTENTIAL STRATEGIC
ALTERNATIVES
PRMO: 0.0003
NO DEBT!!
https://www.otcmarkets.com/otcapi/company/financial-report/342698/content
PRMO is Pink Current again!
https://www.otcmarkets.com/stock/PRMO/overview
NEW WEBSITE: https://www.promrestaurants.com
Prom Resources, Inc.
https://www.barchart.com/stocks/quotes/PRMO/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;HLMA(10,8);SMA(20);BBANDS(20,2);RSI(14,100);STOSL(14,3);SMACD(12,26,9);MOMENT(20);MFI(14,100);SMA(20)&sym=PRMO&grid=1&height=500&studyheight=100
Twitter:
$PRMO many are sleeping on
— Bill's Stocks and Thoughts (@billsstocks1) September 23, 2022
— Bill's Stocks and Thoughts (@billsstocks1) September 20, 2022
Vamos $PRMO https://t.co/5FiYwrYKfi
— FOX (@Jorgeemartineze) September 20, 2022
$SNMN strong support @ 0.0006$NWPN strong support @ 0.0005 with multiple news catalyst $PRMO 0.0003 holding nicely
— Savage (@KEdelbrock) September 13, 2022
$PRMO Everyone is Buying the Dip Right Now.Hoarding Shares,... https://t.co/mNJLOKlEGH
— Anita Mccormick (@AnitaMc26910087) September 13, 2022
Starting to load $PAOG. $PRMO has great chart potential on an 0004 break. Plus PRMO has the custodian that ran SPOM big back in the day
— Bill's Stocks and Thoughts (@billsstocks1) September 9, 2022
$prmo
— mike ferr (@ferrante821) September 10, 2022
The loading is off the hook
Sooner or later it will run
$VNUE After Christmas went from 0037 to 012 on almost nothing. A couple weeks later, it went to over 04 under worse fundamentals.$PRMO still haven't been filled by the whackers but I'm happy with 14MM
— Bill's Stocks and Thoughts (@billsstocks1) September 6, 2022
$PRMO
— DB Daytrades (@DB_Daytrades) September 6, 2022
Daily view of levels of interest. Need buyers to step in and break T5, I expect the day this happens we see immense volume step in and form T4 as a new based support moving forward. Alerts on watch. pic.twitter.com/FrOcPqeXzx
Ok let’s get $PRMO going soon 😎
— 🇵🇭PinayTigerTrades🗯 (@Brown_chickHB) September 1, 2022
$BYOC far from done. $PRMO chart indicating it could be next
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
Event based run with $CZNI vibes, possibly more. Volume precedes price on the chart. Also watching $PRMO (same custodian as the guy who ran $SPOM big back in 2020) for a trips run. Let's go $BYOC.
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
PRMO: 0.0003
NO DEBT!!
https://www.otcmarkets.com/otcapi/company/financial-report/342698/content
PRMO is Pink Current again!
https://www.otcmarkets.com/stock/PRMO/overview
NEW WEBSITE: https://www.promrestaurants.com
Prom Resources, Inc.
https://www.barchart.com/stocks/quotes/PRMO/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;HLMA(10,8);SMA(20);BBANDS(20,2);RSI(14,100);STOSL(14,3);SMACD(12,26,9);MOMENT(20);MFI(14,100);SMA(20)&sym=PRMO&grid=1&height=500&studyheight=100
Twitter:
$PRMO many are sleeping on
— Bill's Stocks and Thoughts (@billsstocks1) September 23, 2022
— Bill's Stocks and Thoughts (@billsstocks1) September 20, 2022
Vamos $PRMO https://t.co/5FiYwrYKfi
— FOX (@Jorgeemartineze) September 20, 2022
$SNMN strong support @ 0.0006$NWPN strong support @ 0.0005 with multiple news catalyst $PRMO 0.0003 holding nicely
— Savage (@KEdelbrock) September 13, 2022
$PRMO Everyone is Buying the Dip Right Now.Hoarding Shares,... https://t.co/mNJLOKlEGH
— Anita Mccormick (@AnitaMc26910087) September 13, 2022
Starting to load $PAOG. $PRMO has great chart potential on an 0004 break. Plus PRMO has the custodian that ran SPOM big back in the day
— Bill's Stocks and Thoughts (@billsstocks1) September 9, 2022
$prmo
— mike ferr (@ferrante821) September 10, 2022
The loading is off the hook
Sooner or later it will run
$VNUE After Christmas went from 0037 to 012 on almost nothing. A couple weeks later, it went to over 04 under worse fundamentals.$PRMO still haven't been filled by the whackers but I'm happy with 14MM
— Bill's Stocks and Thoughts (@billsstocks1) September 6, 2022
$PRMO
— DB Daytrades (@DB_Daytrades) September 6, 2022
Daily view of levels of interest. Need buyers to step in and break T5, I expect the day this happens we see immense volume step in and form T4 as a new based support moving forward. Alerts on watch. pic.twitter.com/FrOcPqeXzx
Ok let’s get $PRMO going soon 😎
— 🇵🇭PinayTigerTrades🗯 (@Brown_chickHB) September 1, 2022
$BYOC far from done. $PRMO chart indicating it could be next
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
Event based run with $CZNI vibes, possibly more. Volume precedes price on the chart. Also watching $PRMO (same custodian as the guy who ran $SPOM big back in 2020) for a trips run. Let's go $BYOC.
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
PHARNEXT (ALPHA) : 0.0004
52w: 0.0003 - 0.47
ISIN: FR0011191287
https://pharnext-website.cdn.prismic.io/pharnext-website/ebcbec32-360f-49cd-b437-7eddc96f46f2_2022.09.01_Pharnext_Corporate_Presentation.pdf
Pharnext SA is a France-based biopharmaceutical company. The Company is focused on discovering, developing and licensing new therapeutic solutions (Pleodrugs) and companion tests for unmet medical needs (large and niche markets) by using the Pleotherapy approach. Pharnext SA runs all its own activities, from research through to clinical development (no further than the end of Phase II trials), and then licenses the Pleodrugs to industrial partners. The Company's prime focus is on neurodegenerative diseases and metabolic diseases.
TIme for a strong rebound
Oct 11, 2022 0.0003 0.0004 0.0003 0.0004 0.0004 199,523,353
Oct 10, 2022 0.0003 0.0004 0.0003 0.0004 0.0004 396,974,124
Oct 07, 2022 0.0005 0.0005 0.0003 0.0004 0.0004 123,192,558
Oct 06, 2022 0.0005 0.0005 0.0003 0.0005 0.0005 294,196,761
Oct 05, 2022 0.0005 0.0006 0.0004 0.0005 0.0005 123,497,263
Oct 04, 2022 0.0006 0.0007 0.0005 0.0005 0.0005 191,736,294
Oct 03, 2022 0.0007 0.0007 0.0005 0.0007 0.0007 46,317,244
Sep 30, 2022 0.0006 0.0007 0.0006 0.0006 0.0006 15,620,515
Sep 29, 2022 0.0007 0.0007 0.0006 0.0006 0.0006 41,485,618
Sep 28, 2022 0.0007 0.0007 0.0006 0.0007 0.0007 10,672,772
Sep 27, 2022 0.0007 0.0007 0.0006 0.0007 0.0007 33,726,951
Sep 26, 2022 0.0007 0.0007 0.0005 0.0007 0.0007 40,844,499
Sep 23, 2022 0.0006 0.0007 0.0005 0.0006 0.0006 132,776,089
Sep 22, 2022 0.0006 0.0007 0.0005 0.0006 0.0006 22,317,737
Sep 21, 2022 0.0006 0.0007 0.0005 0.0006 0.0006 34,263,131
Sep 20, 2022 0.0007 0.0007 0.0005 0.0006 0.0006 115,571,628
Sep 19, 2022 0.0006 0.0007 0.0005 0.0007 0.0007 150,285,480
Sep 16, 2022 0.0006 0.0006 0.0005 0.0006 0.0006 56,125,847
Sep 15, 2022 0.0006 0.0006 0.0005 0.0005 0.0005 95,928,061
Sep 14, 2022 0.0006 0.0007 0.0005 0.0005 0.0005 164,548,800
Sep 13, 2022 0.0006 0.0007 0.0006 0.0007 0.0007 128,072,121
Sep 12, 2022 0.0007 0.0008 0.0006 0.0007 0.0007 157,173,145
Sep 09, 2022 0.0007 0.0008 0.0006 0.0007 0.0007 164,825,016
Sep 08, 2022 0.0008 0.0009 0.0007 0.0007 0.0007 127,894,402
Sep 07, 2022 0.0007 0.0008 0.0007 0.0008 0.0008 88,260,975
Sep 06, 2022 0.0008 0.0009 0.0007 0.0008 0.0008 195,743,570
Sep 05, 2022 0.0010 0.0010 0.0008 0.0009 0.0009 198,082,043
Sep 02, 2022 0.0010 0.0010 0.0009 0.0010 0.0010 133,135,160
Sep 01, 2022 0.0011 0.0012 0.0009 0.0010 0.0010 251,242,830
Aug 31, 2022 0.0012 0.0012 0.0010 0.0010 0.0010 191,903,962
Aug 30, 2022 0.0015 0.0017 0.0011 0.0012 0.0012 594,580,263
Aug 29, 2022 0.0012 0.0014 0.0011 0.0014 0.0014 169,438,260
Aug 26, 2022 0.0013 0.0013 0.0011 0.0012 0.0012 234,414,823
Aug 25, 2022 0.0014 0.0015 0.0012 0.0013 0.0013 210,823,492
Aug 24, 2022 0.0014 0.0015 0.0014 0.0015 0.0015 62,187,005
Aug 23, 2022 0.0014 0.0015 0.0013 0.0015 0.0015 333,110,582
Aug 22, 2022 0.0017 0.0018 0.0014 0.0016 0.0016 196,350,156
Aug 19, 2022 0.0018 0.0019 0.0016 0.0016 0.0016 142,825,535
Aug 18, 2022 0.0019 0.0019 0.0017 0.0018 0.0018 166,015,520
Aug 17, 2022 0.0022 0.0022 0.0018 0.0019 0.0019 258,965,506
Aug 16, 2022 0.0020 0.0024 0.0018 0.0022 0.0022 281,321,337
Aug 15, 2022 0.0018 0.0019 0.0016 0.0019 0.0019 167,820,309
Aug 12, 2022 0.0019 0.0020 0.0018 0.0018 0.0018 196,399,229
Aug 11, 2022 0.0022 0.0023 0.0018 0.0019 0.0019 210,827,208
Aug 10, 2022 0.0025 0.0028 0.0020 0.0022 0.0022 308,938,020
Aug 09, 2022 0.0030 0.0033 0.0023 0.0023 0.0023 279,120,794
Aug 08, 2022 0.0053 0.0079 0.0030 0.0031 0.0031 907,078,321
PHARNEXT (ALPHA) : 0.0004
52w: 0.0003 - 0.47
ISIN: FR0011191287
https://pharnext-website.cdn.prismic.io/pharnext-website/ebcbec32-360f-49cd-b437-7eddc96f46f2_2022.09.01_Pharnext_Corporate_Presentation.pdf
Pharnext SA is a France-based biopharmaceutical company. The Company is focused on discovering, developing and licensing new therapeutic solutions (Pleodrugs) and companion tests for unmet medical needs (large and niche markets) by using the Pleotherapy approach. Pharnext SA runs all its own activities, from research through to clinical development (no further than the end of Phase II trials), and then licenses the Pleodrugs to industrial partners. The Company's prime focus is on neurodegenerative diseases and metabolic diseases.
TIme for a strong rebound
Oct 11, 2022 0.0003 0.0004 0.0003 0.0004 0.0004 199,523,353
Oct 10, 2022 0.0003 0.0004 0.0003 0.0004 0.0004 396,974,124
Oct 07, 2022 0.0005 0.0005 0.0003 0.0004 0.0004 123,192,558
Oct 06, 2022 0.0005 0.0005 0.0003 0.0005 0.0005 294,196,761
Oct 05, 2022 0.0005 0.0006 0.0004 0.0005 0.0005 123,497,263
Oct 04, 2022 0.0006 0.0007 0.0005 0.0005 0.0005 191,736,294
Oct 03, 2022 0.0007 0.0007 0.0005 0.0007 0.0007 46,317,244
Sep 30, 2022 0.0006 0.0007 0.0006 0.0006 0.0006 15,620,515
Sep 29, 2022 0.0007 0.0007 0.0006 0.0006 0.0006 41,485,618
Sep 28, 2022 0.0007 0.0007 0.0006 0.0007 0.0007 10,672,772
Sep 27, 2022 0.0007 0.0007 0.0006 0.0007 0.0007 33,726,951
Sep 26, 2022 0.0007 0.0007 0.0005 0.0007 0.0007 40,844,499
Sep 23, 2022 0.0006 0.0007 0.0005 0.0006 0.0006 132,776,089
Sep 22, 2022 0.0006 0.0007 0.0005 0.0006 0.0006 22,317,737
Sep 21, 2022 0.0006 0.0007 0.0005 0.0006 0.0006 34,263,131
Sep 20, 2022 0.0007 0.0007 0.0005 0.0006 0.0006 115,571,628
Sep 19, 2022 0.0006 0.0007 0.0005 0.0007 0.0007 150,285,480
Sep 16, 2022 0.0006 0.0006 0.0005 0.0006 0.0006 56,125,847
Sep 15, 2022 0.0006 0.0006 0.0005 0.0005 0.0005 95,928,061
Sep 14, 2022 0.0006 0.0007 0.0005 0.0005 0.0005 164,548,800
Sep 13, 2022 0.0006 0.0007 0.0006 0.0007 0.0007 128,072,121
Sep 12, 2022 0.0007 0.0008 0.0006 0.0007 0.0007 157,173,145
Sep 09, 2022 0.0007 0.0008 0.0006 0.0007 0.0007 164,825,016
Sep 08, 2022 0.0008 0.0009 0.0007 0.0007 0.0007 127,894,402
Sep 07, 2022 0.0007 0.0008 0.0007 0.0008 0.0008 88,260,975
Sep 06, 2022 0.0008 0.0009 0.0007 0.0008 0.0008 195,743,570
Sep 05, 2022 0.0010 0.0010 0.0008 0.0009 0.0009 198,082,043
Sep 02, 2022 0.0010 0.0010 0.0009 0.0010 0.0010 133,135,160
Sep 01, 2022 0.0011 0.0012 0.0009 0.0010 0.0010 251,242,830
Aug 31, 2022 0.0012 0.0012 0.0010 0.0010 0.0010 191,903,962
Aug 30, 2022 0.0015 0.0017 0.0011 0.0012 0.0012 594,580,263
Aug 29, 2022 0.0012 0.0014 0.0011 0.0014 0.0014 169,438,260
Aug 26, 2022 0.0013 0.0013 0.0011 0.0012 0.0012 234,414,823
Aug 25, 2022 0.0014 0.0015 0.0012 0.0013 0.0013 210,823,492
Aug 24, 2022 0.0014 0.0015 0.0014 0.0015 0.0015 62,187,005
Aug 23, 2022 0.0014 0.0015 0.0013 0.0015 0.0015 333,110,582
Aug 22, 2022 0.0017 0.0018 0.0014 0.0016 0.0016 196,350,156
Aug 19, 2022 0.0018 0.0019 0.0016 0.0016 0.0016 142,825,535
Aug 18, 2022 0.0019 0.0019 0.0017 0.0018 0.0018 166,015,520
Aug 17, 2022 0.0022 0.0022 0.0018 0.0019 0.0019 258,965,506
Aug 16, 2022 0.0020 0.0024 0.0018 0.0022 0.0022 281,321,337
Aug 15, 2022 0.0018 0.0019 0.0016 0.0019 0.0019 167,820,309
Aug 12, 2022 0.0019 0.0020 0.0018 0.0018 0.0018 196,399,229
Aug 11, 2022 0.0022 0.0023 0.0018 0.0019 0.0019 210,827,208
Aug 10, 2022 0.0025 0.0028 0.0020 0.0022 0.0022 308,938,020
Aug 09, 2022 0.0030 0.0033 0.0023 0.0023 0.0023 279,120,794
Aug 08, 2022 0.0053 0.0079 0.0030 0.0031 0.0031 907,078,321
PRMO: 0.0003
NO DEBT!!
https://www.otcmarkets.com/otcapi/company/financial-report/342698/content
PRMO is Pink Current again!
https://www.otcmarkets.com/stock/PRMO/overview
NEW WEBSITE: https://www.promrestaurants.com
Prom Resources, Inc.
https://www.barchart.com/stocks/quotes/PRMO/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;HLMA(10,8);SMA(20);BBANDS(20,2);RSI(14,100);STOSL(14,3);SMACD(12,26,9);MOMENT(20);MFI(14,100);SMA(20)&sym=PRMO&grid=1&height=500&studyheight=100
Twitter:
$PRMO many are sleeping on
— Bill's Stocks and Thoughts (@billsstocks1) September 23, 2022
— Bill's Stocks and Thoughts (@billsstocks1) September 20, 2022
Vamos $PRMO https://t.co/5FiYwrYKfi
— FOX (@Jorgeemartineze) September 20, 2022
$SNMN strong support @ 0.0006$NWPN strong support @ 0.0005 with multiple news catalyst $PRMO 0.0003 holding nicely
— Savage (@KEdelbrock) September 13, 2022
$PRMO Everyone is Buying the Dip Right Now.Hoarding Shares,... https://t.co/mNJLOKlEGH
— Anita Mccormick (@AnitaMc26910087) September 13, 2022
Starting to load $PAOG. $PRMO has great chart potential on an 0004 break. Plus PRMO has the custodian that ran SPOM big back in the day
— Bill's Stocks and Thoughts (@billsstocks1) September 9, 2022
$prmo
— mike ferr (@ferrante821) September 10, 2022
The loading is off the hook
Sooner or later it will run
$VNUE After Christmas went from 0037 to 012 on almost nothing. A couple weeks later, it went to over 04 under worse fundamentals.$PRMO still haven't been filled by the whackers but I'm happy with 14MM
— Bill's Stocks and Thoughts (@billsstocks1) September 6, 2022
$PRMO
— DB Daytrades (@DB_Daytrades) September 6, 2022
Daily view of levels of interest. Need buyers to step in and break T5, I expect the day this happens we see immense volume step in and form T4 as a new based support moving forward. Alerts on watch. pic.twitter.com/FrOcPqeXzx
Ok let’s get $PRMO going soon 😎
— 🇵🇭PinayTigerTrades🗯 (@Brown_chickHB) September 1, 2022
$BYOC far from done. $PRMO chart indicating it could be next
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
Event based run with $CZNI vibes, possibly more. Volume precedes price on the chart. Also watching $PRMO (same custodian as the guy who ran $SPOM big back in 2020) for a trips run. Let's go $BYOC.
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
PRMO: 0.0003
NO DEBT!!
https://www.otcmarkets.com/otcapi/company/financial-report/342698/content
PRMO is Pink Current again!
https://www.otcmarkets.com/stock/PRMO/overview
NEW WEBSITE: https://www.promrestaurants.com
Prom Resources, Inc.
https://www.barchart.com/stocks/quotes/PRMO/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;HLMA(10,8);SMA(20);BBANDS(20,2);RSI(14,100);STOSL(14,3);SMACD(12,26,9);MOMENT(20);MFI(14,100);SMA(20)&sym=PRMO&grid=1&height=500&studyheight=100
Twitter:
$PRMO many are sleeping on
— Bill's Stocks and Thoughts (@billsstocks1) September 23, 2022
— Bill's Stocks and Thoughts (@billsstocks1) September 20, 2022
Vamos $PRMO https://t.co/5FiYwrYKfi
— FOX (@Jorgeemartineze) September 20, 2022
$SNMN strong support @ 0.0006$NWPN strong support @ 0.0005 with multiple news catalyst $PRMO 0.0003 holding nicely
— Savage (@KEdelbrock) September 13, 2022
$PRMO Everyone is Buying the Dip Right Now.Hoarding Shares,... https://t.co/mNJLOKlEGH
— Anita Mccormick (@AnitaMc26910087) September 13, 2022
Starting to load $PAOG. $PRMO has great chart potential on an 0004 break. Plus PRMO has the custodian that ran SPOM big back in the day
— Bill's Stocks and Thoughts (@billsstocks1) September 9, 2022
$prmo
— mike ferr (@ferrante821) September 10, 2022
The loading is off the hook
Sooner or later it will run
$VNUE After Christmas went from 0037 to 012 on almost nothing. A couple weeks later, it went to over 04 under worse fundamentals.$PRMO still haven't been filled by the whackers but I'm happy with 14MM
— Bill's Stocks and Thoughts (@billsstocks1) September 6, 2022
$PRMO
— DB Daytrades (@DB_Daytrades) September 6, 2022
Daily view of levels of interest. Need buyers to step in and break T5, I expect the day this happens we see immense volume step in and form T4 as a new based support moving forward. Alerts on watch. pic.twitter.com/FrOcPqeXzx
Ok let’s get $PRMO going soon 😎
— 🇵🇭PinayTigerTrades🗯 (@Brown_chickHB) September 1, 2022
$BYOC far from done. $PRMO chart indicating it could be next
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
Event based run with $CZNI vibes, possibly more. Volume precedes price on the chart. Also watching $PRMO (same custodian as the guy who ran $SPOM big back in 2020) for a trips run. Let's go $BYOC.
— Bill's Stocks and Thoughts (@billsstocks1) August 31, 2022
VNET GROUP INC. (VNET) : 4.775 - 6.92%
VNET Group Inc, formerly 21Vianet Group Inc, is a carrier-neutral Internet data center services provider. The Company hosts its customers' servers and networking equipment and provides interconnectivity. The Company also provides managed network services to enable customers to deliver data across the Internet through its data transmission network and smart routing technology. The Company provides value-added services, such as content delivery network services, virtual private network services and last-mile wired broadband services. It offers public cloud services, private cloud and hybrid services. The Company also offers container-based data center service. The Company's service offerings include hosting and related services, and managed network services. The Company provides hosting and related services to house servers and networking equipment in its data centers and connects them through its data transmission network, and offers other hosting related value-added services.
Sept 13 (Reuters) - VNET Group Inc :
* VNET ANNOUNCES RECEIPT OF PRELIMINARY NON-BINDING PROPOSAL
TO
ACQUIRE ALL OF ITS SHARES AND FORMATION OF SPECIAL COMMITTEE TO
REVIEW THE PROPOSAL
* VNET GROUP INC - RECEIVED A PRELIMINARY NON-BINDING
PROPOSAL
LETTER FROM JOSH SHENG CHEN, FOUNDER OF COMPANY
* VNET GROUP INC - PROPOSAL TO ACQUIRE ALL OF OUTSTANDING
ORDINARY SHARES OF COMPANY FOR $8.20 IN CASH PER AMERICAN DEPOSITARY SHARE
* VNET GROUP INC - FORMED COMMITTEE TO EVALUATE AND CONSIDER
PROPOSED TRANSACTION AS WELL AS OTHER POTENTIAL STRATEGIC
ALTERNATIVES
VNET GROUP INC. (VNET) : 4.775 - 6.92%
VNET Group Inc, formerly 21Vianet Group Inc, is a carrier-neutral Internet data center services provider. The Company hosts its customers' servers and networking equipment and provides interconnectivity. The Company also provides managed network services to enable customers to deliver data across the Internet through its data transmission network and smart routing technology. The Company provides value-added services, such as content delivery network services, virtual private network services and last-mile wired broadband services. It offers public cloud services, private cloud and hybrid services. The Company also offers container-based data center service. The Company's service offerings include hosting and related services, and managed network services. The Company provides hosting and related services to house servers and networking equipment in its data centers and connects them through its data transmission network, and offers other hosting related value-added services.
Sept 13 (Reuters) - VNET Group Inc :
* VNET ANNOUNCES RECEIPT OF PRELIMINARY NON-BINDING PROPOSAL
TO
ACQUIRE ALL OF ITS SHARES AND FORMATION OF SPECIAL COMMITTEE TO
REVIEW THE PROPOSAL
* VNET GROUP INC - RECEIVED A PRELIMINARY NON-BINDING
PROPOSAL
LETTER FROM JOSH SHENG CHEN, FOUNDER OF COMPANY
* VNET GROUP INC - PROPOSAL TO ACQUIRE ALL OF OUTSTANDING
ORDINARY SHARES OF COMPANY FOR $8.20 IN CASH PER AMERICAN DEPOSITARY SHARE
* VNET GROUP INC - FORMED COMMITTEE TO EVALUATE AND CONSIDER
PROPOSED TRANSACTION AS WELL AS OTHER POTENTIAL STRATEGIC
ALTERNATIVES
QUINCE THERAPEUTICS (QNCX): 1.04 - 8.77%
52w: 1.04 - 91.76
Quince Therapeutics, Inc., formerly Cortexyme, Inc., is a biopharmaceutical company. The Company is focused on advancing precision therapeutics targeting debilitating and rare diseases. The Company has discovered a bone-targeting drug platform capable of delivering small molecules, peptides, or large molecules directly to the site of broad bone fractures and disease designed to promote more healing with fewer off-target safety concerns. The Company’s lead compound, NOV004, is an anabolic peptide engineered to target and concentrate at the bone fracture site. Its discovery pipeline is focused on expanding across multiple skeletal therapeutic indications, including osteogenesis imperfecta, fractures, spinal fusion, and other severe diseases of bone such as cancer or infection. The Company's pipeline also includes legacy neuroscience and antiviral programs available for out-licensing, which include COR588, COR388, COR852 and COR803.
Strong cash position of approximately $105 million provides operating runway into the second half of 2025
Shares Outstanding 36.1M
Float 24.88M
Total Cash Per Share (mrq) 2.88
Total Debt (mrq) 524k
QUINCE THERAPEUTICS (QNCX): 1.04 - 8.77%
52w: 1.04 - 91.76
Quince Therapeutics, Inc., formerly Cortexyme, Inc., is a biopharmaceutical company. The Company is focused on advancing precision therapeutics targeting debilitating and rare diseases. The Company has discovered a bone-targeting drug platform capable of delivering small molecules, peptides, or large molecules directly to the site of broad bone fractures and disease designed to promote more healing with fewer off-target safety concerns. The Company’s lead compound, NOV004, is an anabolic peptide engineered to target and concentrate at the bone fracture site. Its discovery pipeline is focused on expanding across multiple skeletal therapeutic indications, including osteogenesis imperfecta, fractures, spinal fusion, and other severe diseases of bone such as cancer or infection. The Company's pipeline also includes legacy neuroscience and antiviral programs available for out-licensing, which include COR588, COR388, COR852 and COR803.
Strong cash position of approximately $105 million provides operating runway into the second half of 2025
Shares Outstanding 36.1M
Float 24.88M
Total Cash Per Share (mrq) 2.88
Total Debt (mrq) 524k
GAOTU TECHEDU INC -A- ADR 1,11 -5,93%
52w: 1.11 - 4.58
2 year high 142.7
Gaotu Techedu Inc, formerly GSX Techedu Inc, is a China-based holding company principally involved in the provision of technology-driven education services. Through its subsidiaries, the Company is engaged in the provision of online K-12 after-school tutoring services. It also offers foreign language, professional and interest courses. The Company conducts its businesses in Mainland China.
GAOTU TECHEDU INC -A- ADR 1,11 -5,93%
52w: 1.11 - 4.58
2 year high 142.7
Gaotu Techedu Inc, formerly GSX Techedu Inc, is a China-based holding company principally involved in the provision of technology-driven education services. Through its subsidiaries, the Company is engaged in the provision of online K-12 after-school tutoring services. It also offers foreign language, professional and interest courses. The Company conducts its businesses in Mainland China.